Woolsey Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Woolsey Pharmaceuticals has a total of 59 patents globally, out of which 4 have been granted. Of these 59 patents, more than 98% patents are active. The USA is where Woolsey Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Canada. Parallelly, the United States seems to be the main focused R&D center of Woolsey Pharmaceuticals and is also the origin country of the firm.

Woolsey Pharmaceuticals was founded in the year 2019 by David M. Geliebter and Sven M. Jacobson. The company is a pharmaceutical firm that specializes in reinventing ways to treat some of the world’s most challenging diseases.

Do read about some of the most popular patents of Woolsey Pharmaceuticals which have been covered by us in this article and also you can find Woolsey Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Woolsey Pharmaceuticals patent portfolio.

How many patents does Woolsey Pharmaceuticals have?

Woolsey Pharmaceuticals has a total of 59 patents globally. These patents belong to 20 unique patent families. Out of 59 patents, 58 patents are active.

How Many Patents did Woolsey Pharmaceuticals File Every Year?

Woolsey Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantWoolsey Pharmaceuticals Applications FiledWoolsey Pharmaceuticals Patents Granted
20229
202139
2020
2019

How many Woolsey Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Woolsey Pharmaceuticals Patent Portfolio

How Many Patents did Woolsey Pharmaceuticals File in Different Countries?

Woolsey Pharmaceuticals Worldwide Patent Filing

Where are Research Centres of Woolsey Pharmaceuticals Patents Located?

The R&D Centre of patents filed by Woolsey Pharmaceuticals is in the US.

Most Cited Woolsey Pharmaceuticals Patent

US11642352B2 is the most popular patent in the Woolsey Pharmaceuticals portfolio. It has received 2 citations so far.

List of Woolsey Pharmaceuticals Patents

Woolsey Pharmaceuticals PatentsTitle
US11779588B2Method Of Treating Amyotrophic Lateral Sclerosis
US11771704B1Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease
US11666583B2Methods Of Treating Cortical Dementia Associated Wandering
US11642352B2Methods Of Treating Wandering In Lewy Dody Dementia
US20230321114A1Methods Of Treating Age Related Cognitive Decline
US20230310447A1Methods Of Treating Age Related Cognitive Decline
US20230285409A1Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia
US20230263806A1Methods Of Treating Proteinopathies
US20230255980A1Taste Masking Oral Formulations Of Fasudil
US20230248739A1Methods Of Treating Cortical Dementia Associated Wandering
US20230226073A1Methods Of Treating Proteinopathy Associated Wandering
US20230201219A1Methods Of Treating Agitation And Other Dementia Associated Behavioral Symptoms
US20230190765A1Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease
US20230080958A1Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances
US20220125799A1Methods Of Treating 4 Repeat Tauopathies
US20220047607A1Methods Of Treating Neurodevelopmental Disorders
EP4232041A1Methods Of Treating 4 Repeat Tauopathies
EP4203961A1Methods Of Treating Age Related Cognitive Decline
EP4203960A1Methods Of Treating Age Related Cognitive Decline
EP4181925A1Methods Of Treating Proteinopathies
EP4171564A1Methods Of Treating Neurodevelopmental Disorders
EP4164652A1Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia
EP4138842A1Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease
EP4125910A1Methods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia
EP4125879A1Methods Of Treating Proteinopathy  Associated Wandering
EP4103187A1Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances
EP4087564A1Methods Of Treating Cortical Dementia Associated Wandering
WO2023158789A1Oral Formulations Of Fasudil With Ion Exchange Resin
WO2023158787A1Taste Masking Oral Formulations Of Fasudil
WO2023097151A1Methods Of Treating Agitation And Other Dementia Associated Behavioral Symptoms
WO2023086468A1Method Of Treating Amyotrophic Lateral Sclerosis And Dosing Regimen For Same
WO2023063959A1Method Of Treating Amyotrophic Lateral Sclerosis
WO2022245719A1Methods Of Treating Depression And Anxiety
WO2022245708A1Methods Of Treating Depression And Anxiety
CA3193561A1Methods Of Treating 4 Repeat Tauopathies
CA3188722A1Methods Of Treating Age Related Cognitive Decline
CA3188718A1Methods Of Treating Age Related Cognitive Decline
CA3184122A1Methods Of Treating Proteinopathies
CA3180436A1Methods Of Treating Neurodevelopmental Disorders
CA3180411A1Methods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia
CA3175183A1Methods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease
CA3170073A1Methods Of Treating Proteinopathy  Associated Wandering
CA3169944A1Methods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia
CA3165379A1Methods Of Treating Pseudobulbar Affect And Other Emotional Disturbances
CA3162382A1Methods Of Treating Cortical Dementia Associated Wandering
JP2023530120AMethods Of Using Rho Kinase Inhibitors To Treat Vascular Dementia
JP2023523706AMethods Of Using Rho Kinase Inhibitors To Treat Alzheimer’S Disease
JP2023518707AMethods Of Treating Wandering Associated With Proteinopathy
JP2023509970AMethods Of Treating Wandering Associated With Cortical Dementia
MX2023002396AMethods To Treat Age Related Cognitive Impairment
MX2023004523ATauopathy Treatment Methods Of 4 Repeats
MX2023002165AMethods To Treat Age Related Cognitive Impairment
MX2023000600AProtein Disease Treatment Methods
MX2022012957AMethods Of Use Of Rho Kinase Inhibitors To Treat Alzheimer’S Disease
MX2022011519AMethods Of Using Rho Kinase Inhibitors To Treat Frontotemporal Dementia
MX2022011518AMethods To Treat Wandering Associated With Proteinopathy
MX2022009479AMethods Of Treating Pseudobulbar Affect And Other Emotional Disturbances.
MX2022008513AMethods Of Treating Cortical Dementia Associated Wandering.
US20210401853A1Methods Of Treating Neurodevelopmental Disorders

What are Woolsey Pharmaceuticals’ key innovation segments?

What Technologies are Covered by Woolsey Pharmaceuticals?

The chart below distributes patents filed by Woolsey Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Woolsey Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Woolsey Pharmaceuticals’ search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Woolsey Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.